News

Parkinson's Foundation & WHO Foundation Announce Partnership to Advance Global Care

NEW YORK & MIAMI (June 9, 2026) —The Parkinson’s Foundation today announced a partnership with the WHO Foundation aimed at improving access to medicines for Parkinson’s disease (PD) in Africa.

News

Parkinson’s Foundation Applauds Vermont’s Landmark Ban of Dangerous Pesticide Linked to Parkinson’s Disease

WASHINGTON, D.C. (May 26, 2026) - Today, the Parkinson’s Foundation applauded Vermont for being the first state in the nation to ban paraquat, a dangerous pesticide linked to Parkinson’s disease (PD).

News

New Parkinson's Foundation PD Trial Navigator Program Identifies 2,000+ Potential Participants for NEULARK Clinical Trial

NEW YORK (May 26, 2026) — To accelerate Parkinson's disease (PD) research and connect eligible participants with clinical trials, the Parkinson’s Foundation announced the first major milestone of its new PD Trial Navigator pilot program.

News

Parkinson’s Foundation Invests Nearly $600K in Innovative Care Grants

NEW YORK & MIAMI (May 19, 2026) - The Parkinson’s Foundation has announced an investment of nearly $600,000 toward three award grants to fund innovative practices in clinical care that can improve the health and quality of life for people with Parkinson’s disease (PD).

News

Parkinson’s Foundation Applauds the Appointment of the National Parkinson’s Plan Advisory Council

Washington, D.C. (April 10, 2026) - The Parkinson’s Foundation applauds today’s Department of Health and Human Services’ (HHS) announcement appointing the Advisory Council created by the National Plan to End Parkinson’s Act (P.L. 118-66).

News

Leading Parkinson’s Organizations Urge Congress to Preserve Progress and Strengthen Parkinson’s Research Funding at the National Institutes of Health

NEW YORK, NY (April 3, 2026) — As Congress reviews the President’s federal budget proposal for Fiscal Year (FY) 2027, the three leading national Parkinson’s advocacy organizations — on behalf of the 1.2 million Americans living with Parkinson’s and related conditions — urge lawmakers to increase investment in the National Institutes of Health (NIH).